These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 21782548)
1. Pinworm and TNKS inhibitors, an eccentric duo to derail the oncogenic WNT pathway. Ouelaa-Benslama R; Emami S Clin Res Hepatol Gastroenterol; 2011 Sep; 35(8-9):534-8. PubMed ID: 21782548 [TBL] [Abstract][Full Text] [Related]
2. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth. Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443 [TBL] [Abstract][Full Text] [Related]
3. Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of β-Catenin Degradation-Competent Axin Puncta. Martino-Echarri E; Brocardo MG; Mills KM; Henderson BR PLoS One; 2016; 11(3):e0150484. PubMed ID: 26930278 [TBL] [Abstract][Full Text] [Related]
4. Structure, Dynamics, and Functionality of Tankyrase Inhibitor-Induced Degradasomes. Thorvaldsen TE; Pedersen NM; Wenzel EM; Schultz SW; Brech A; Liestøl K; Waaler J; Krauss S; Stenmark H Mol Cancer Res; 2015 Nov; 13(11):1487-501. PubMed ID: 26124443 [TBL] [Abstract][Full Text] [Related]
5. The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase. Okada-Iwasaki R; Takahashi Y; Watanabe Y; Ishida H; Saito J; Nakai R; Asai A Mol Cancer Ther; 2016 Jul; 15(7):1525-34. PubMed ID: 27196752 [TBL] [Abstract][Full Text] [Related]
6. [1,2,4]triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: antagonists of the Wnt pathway that inhibit tankyrases 1 and 2 via novel adenosine pocket binding. Shultz MD; Kirby CA; Stams T; Chin DN; Blank J; Charlat O; Cheng H; Cheung A; Cong F; Feng Y; Fortin PD; Hood T; Tyagi V; Xu M; Zhang B; Shao W J Med Chem; 2012 Feb; 55(3):1127-36. PubMed ID: 22260203 [TBL] [Abstract][Full Text] [Related]
7. Evidence for tankyrases as antineoplastic targets in lung cancer. Busch AM; Johnson KC; Stan RV; Sanglikar A; Ahmed Y; Dmitrovsky E; Freemantle SJ BMC Cancer; 2013 Apr; 13():211. PubMed ID: 23621985 [TBL] [Abstract][Full Text] [Related]
8. Expression of TNKS1 is correlated with pathologic grade and Wnt/β-catenin pathway in human astrocytomas. Tang B; Wang J; Fang J; Jiang B; Zhang M; Wang Y; Yang Z J Clin Neurosci; 2012 Jan; 19(1):139-43. PubMed ID: 22154485 [TBL] [Abstract][Full Text] [Related]
9. A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice. Waaler J; Machon O; Tumova L; Dinh H; Korinek V; Wilson SR; Paulsen JE; Pedersen NM; Eide TJ; Machonova O; Gradl D; Voronkov A; von Kries JP; Krauss S Cancer Res; 2012 Jun; 72(11):2822-32. PubMed ID: 22440753 [TBL] [Abstract][Full Text] [Related]
11. Oncogenic Wnt/β-catenin signalling pathways in the cancer-resistant epididymis have implications for cancer research. Wang K; Li N; Yeung CH; Li JY; Wang HY; Cooper TG Mol Hum Reprod; 2013 Feb; 19(2):57-71. PubMed ID: 23155044 [TBL] [Abstract][Full Text] [Related]
12. Gadd45a regulates matrix metalloproteinases by suppressing DeltaNp63alpha and beta-catenin via p38 MAP kinase and APC complex activation. Hildesheim J; Belova GI; Tyner SD; Zhou X; Vardanian L; Fornace AJ Oncogene; 2004 Mar; 23(10):1829-37. PubMed ID: 14647429 [TBL] [Abstract][Full Text] [Related]
13. Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells. Kulak O; Chen H; Holohan B; Wu X; He H; Borek D; Otwinowski Z; Yamaguchi K; Garofalo LA; Ma Z; Wright W; Chen C; Shay JW; Zhang X; Lum L Mol Cell Biol; 2015 Jul; 35(14):2425-35. PubMed ID: 25939383 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of tankyrases induces Axin stabilization and blocks Wnt signalling in breast cancer cells. Bao R; Christova T; Song S; Angers S; Yan X; Attisano L PLoS One; 2012; 7(11):e48670. PubMed ID: 23144924 [TBL] [Abstract][Full Text] [Related]
15. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer. Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872 [TBL] [Abstract][Full Text] [Related]
17. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin. Cui L; Zhao J; Liu J Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930 [TBL] [Abstract][Full Text] [Related]
18. The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma. Dahmani R; Just PA; Perret C Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):709-13. PubMed ID: 21778132 [TBL] [Abstract][Full Text] [Related]
19. WNT signaling pathway and stem cell signaling network. Katoh M; Katoh M Clin Cancer Res; 2007 Jul; 13(14):4042-5. PubMed ID: 17634527 [TBL] [Abstract][Full Text] [Related]
20. Protein kinase C ζ is a positive modulator of canonical Wnt signaling pathway in tumoral colon cell lines. Luna-Ulloa LB; Hernández-Maqueda JG; Santoyo-Ramos P; Castañeda-Patlán MC; Robles-Flores M Carcinogenesis; 2011 Nov; 32(11):1615-24. PubMed ID: 21859831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]